Logo - springer
Slogan - springer

Springer Healthcare | Oncology and Therapy

Oncology and Therapy

Oncology and Therapy

ISSN: 2366-1070 (print version)
ISSN: 2366-1089 (electronic version)

Journal no. 40487

Learn more about the metrics of this journal

Aims and Scope

Oncology and Therapy is an international, open access, peer-reviewed (single-blind), and rapid publication journal. The scope of the journal is broad and will consider all scientifically sound research from clinical (all phases), observational (real-world), health economics and outcomes, pharmacokinetics, patient-reported outcomes and quality of life studies, on all aspects of oncology and cancer-related conditions.

The journal is of interest to a broad audience of pharmaceutical and healthcare professionals and publishes original research, reviews, case reports/series, trial protocols and short communications such as commentaries and editorials. Oncology and Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an international and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of quality research, which may be considered of insufficient interest by other journals.

Rapid Publication

The journal’s publication timelines aim for a rapid peer review of 2 weeks. If an article is accepted it will be published 3–4 weeks from acceptance. The rapid timelines are achieved through the combination of a dedicated in-house editorial team, who manage article workflow, and an extensive Editorial and Advisory Board who assist with peer review. This allows the journal to support the rapid dissemination of research, whilst still providing robust peer review. Combined with the journal’s open access model this allows for the rapid, efficient communication of the latest research and reviews, fostering the advancement of oncologic therapies.

Personal Service

The journal’s dedicated in-house editorial team offer a personal “concierge service” meaning authors will always have an editorial contact able to update them on the status of their manuscript.  The editorial team check all manuscripts to ensure that articles conform to the most recent COPE, GPP and ICMJE publishing guidelines. This supports the publication of ethically sound and transparent research.

Enhanced Digital Features

Oncology and Therapy offers a range of additional enhanced digital features designed to increase visibility, readership, and the educational value of the content. Each paper is accompanied by a bulleted summary slide, giving a time-efficient overview of the content to a wide readership. Articles also have the option to include other enhanced digital features including (but not limited to) slide sets, videos, video abstracts, podcasts, infographics and animations. All these enhanced digital features are open access and are peer reviewed to the same high standard as the article itself. By having a choice of media not limited to text, figures and tables alone, readers may receive information more effectively, whilst being reassured that the content has undergone the same rigorous peer review as the original article. Offering succinct multimedia formats can support time-pressed healthcare professionals in keeping on top of recently published research. For questions relating specifically to these features, please contact adisdigitalfeatures@springer.com.

Plain Language Summaries

Articles published in Oncology and Therapy may be accompanied by plain language summaries to assist non-experts (including non-specialists, patients, caregivers and others) in understanding important medical advances. Both the enhanced digital features and plain language summaries can help to reach a broader audience thus supporting the effective dissemination of research.

Publication Fees

Upon acceptance of an article, authors will be required to pay the article processing charge and open access fee of €340 / $380 per typeset page. The journal will consider fee discounts and waivers for developing countries and this is decided on a case by case basis. Considering the time and effort required for a detailed peer review we also reward our regular reviewers with the opportunity to publish without article processing charges (pending peer review) for every three reviews completed per calendar year. 

Peer Review Process

Upon submission, manuscripts are assessed by the editorial team to ensure they fit within the aims and scope of the journal and are also checked for plagiarism. All suitable submissions are then subject to a comprehensive single-blind peer review. Reviewers are selected based on their relevant expertise and publication history in the subject area. The journal has an extensive pool of editorial and advisory board members who have been selected to assist with peer review based on the afore-mentioned criteria.

At least two extensive reviews are required to make the editorial decision. Where reviewer recommendations are conflicted, the editorial board will be contacted for further advice and a presiding decision. Manuscripts are then either accepted, rejected or authors are required to make major or minor revisions (both reviewer comments and editorial comments may need to be addressed). Once a revised manuscript is re-submitted, it is assessed along with the responses to reviewer comments and if it has been adequately revised it will be accepted for publication. Accepted manuscripts are then copyedited and typeset by the production team before online publication. Appeals against decisions following peer review are considered on a case by case basis and should be sent to the journal editor.

For more information about the journal, please contact luke.lambeth@springer.com or see the News page for the latest journal offers.

Related subjects » Springer Healthcare

Abstracted/Indexed in 

EMBASE, Google Scholar, DOAJ, EBSCO Discovery Service, EBSCO TOC Premier, Emerging Sources Citation Index, INIS Atomindex, OCLC WorldCat Discovery Service, ProQuest Central, ProQuest Family Health Database, ProQuest Health & Medical Collection, ProQuest Health Research Premium Collection, ProQuest Nursing & Allied Health Database, ProQuest Pharma Collection, ProQuest Public Health Database, ProQuest-ExLibris Primo, ProQuest-ExLibris Summon

For authors and editors

  • Aims and Scope

    Aims and Scope

    Close

    Oncology and Therapy is an international, open access, peer-reviewed, rapid-publication journal (peer review in 2 weeks, published 3–4 weeks from acceptance).

    The journal aims to be a key educational tool to help healthcare and industry professionals alike to assess and further understand the place of innovative therapies within the field of oncology by providing comprehensive insights into the most up-to-date research.

    The journal is of interest to a broad, global audience of pharmaceutical and healthcare professionals from all disciplines of oncology, and publishes original research, reviews, case reports, trial protocols and commentaries on all aspects of oncology and research around solid tumours, haematological malignancies and cancer-related conditions, including, but not limited to:
         •      clinical studies (all phases)
         •      observational (real-world) research
         •      health economics and outcomes research
         •      immunotherapy
         •      biomarkers
         •      pharmacokinetics
         •      pharmacoeconomics
         •      public health
         •      patient-reported outcomes
         •      patient care and management
         •      quality of life

    Articles published in Oncology and Therapy may be accompanied by Plain Language Summaries to assist non-experts (including non-specialists, patients, caregivers and others) in understanding important medical advances.

    Moving forward from traditional publishing, Oncology and Therapy offers a range of additional enhanced features designed to increase visibility, readership, and the educational value of the content. Each paper is accompanied by a bulleted Summary slide, giving a time-efficient overview of the content to a wide readership. Authors also have the option to include various other types of enhanced features including slide sets, videos and animations. All enhanced features are open access and are peer reviewed to the same high standard as the article itself.

    Oncology and Therapy is published under the Creative Commons Attribution-Noncommercial License, which allows users to read, copy, distribute, and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited. The author assigns the exclusive right to any commercial use of the article to Springer. For more information about the Creative Commons Attribution-Noncommercial License, click here: http://creativecommons.org/licenses/by-nc/4.0.

    The journal follows a single-blind peer review procedure and a minimum of 2 reviewers are required for every manuscript.

    Upon acceptance of your article for publication, you will be required to pay the article processing charge of €340 / $380 per typeset page. This will enable you to keep the copyright; you are simply assigning the exclusive right to any commercial use of the article to Springer. Your article will be immediately and permanently available with open access. The journal will consider fee discounts for developing countries and this is decided on a case by case basis.

    Peer Review Process

    Upon submission, manuscripts are assessed by the editorial team to ensure they fit within the aims and scope of the journal and are also checked for plagiarism. All suitable submissions are then subject to a comprehensive single-blind peer review. Reviewers are selected based on their relevant expertise and publication history in the subject area. The journal has an extensive pool of editorial and advisory board members who have been selected to assist with peer review based on the afore-mentioned criteria.

    At least two extensive reviews are required to make the editorial decision. Where reviewer recommendations are conflicted, the editorial board will be contacted for further advice and a presiding decision. Manuscripts are then either accepted, rejected or authors are required to make major or minor revisions (both reviewer comments and editorial comments may need to be addressed). Once a revised manuscript is re-submitted, it is assessed along with the responses to reviewer comments and if it has been adequately revised it will be accepted for publication. Appeals against decisions following peer review are considered on a case by case basis and should be sent to the journal editor. Accepted manuscripts are then copyedited and typeset by the production team before online publication.

    For more information about the journal, please contact luke.lambeth@springer.com or see the News page for the latest journal offers.

  • Submit Online
  • Instructions for Authors (pdf, 474 kB)
  • Author Disclosure Form (docx, 45 kB)
  • Compliance with Ethical Policies
  • Copyright Information

    Copyright Information

    Close

    Copyright Information

    Open Access Oncology and Therapy is published under the Creative Commons Attribution-Noncommercial License, which allows users to read, copy, distribute, and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited. The author assigns the exclusive right to any commercial use of the article to Springer. For more information about the Creative Commons Attribution-Noncommercial License, click here: http://creativecommons.org/licenses/by-nc/4.0

    Journal ownership: Springer Healthcare

    Copyright of articles: © The Author(s)

Alerts for this journal

 

Get the table of contents of every new issue published in Oncology and Therapy.


Additional information